Search Weight Loss Topics:

Page 31«..1020..30313233..4050..»

Category Archives: Testosterone

Why Men Are Turning to Cosmetic Procedures for a Competitive Edge in the Boardroom – Robb Report

Posted: August 17, 2020 at 4:00 pm

Not long ago, a successful Silicon Valley tech entrepreneur decided to make a risky new investment hed been toying with for years. Id just hit 50 and sold my second company, he recalls. I looked at myself and thought, I have another 20 years of work in front of me, so Im going to go do this now.

Marc paid $25,000 for a lower face-lift and a nose job. (His name and those of the other patients who spoke to Robb Report have been changed at their request.) One of the best investments Ive made, he says. Unlike other investments in Marcs career, this one was a closely guarded secret, known only to his doctor, wife, brotherand now you.

Nine out of 10 cosmetic procedures in the US are performed on women. Yet to Marc and a growing number of high-flying men, nips, tucks and injections have become stealth weapons to deploy in a Darwinian battle for corporate survival. I play in the high-tech and start-up world, where older individuals will be passed over, says Marc, who also got his first Botox shots this year. The software wars take a lot of energy and commitment. I simply aligned my outer appearance with my inner perspective.

Its not just about advantage in a youth-oriented workplace. As gender roles evolve, vanity is losing much of its stigma for men in general. The beauty buffet, once ladies-only, is now open to all, with men increasingly moving from the hors doeuvres (grooming, beard cultivation, skin care, dieting and exercising) to the appetizers (cosmetic dentistry, hair replacement, hormone therapy) and on to the entrees (Botox, fillers, non-invasive fat reduction) before ordering up the piece de resistance: plastic surgery. Chanel, Fenty and Tom Ford now also offer a once-unthinkable side dish: makeup for men, leading them into the realm of foundation and eyebrow gel.

Tom Fords makeup for men.Tom Ford

Men dont use the word beauty, of course. Women talk about beauty. Men talk about vitality, virility, competitive edgethats a masculine way of describing what is essentially vanity, says William Liu, professor of psychology at the University of Maryland, who specializes in issues around masculinity. But what they are really talking about is warding off existential anxiety around death.

The idea of stigma has changed, says Marc. Women should not always have to look made-up, and men can wear makeup. Those mores are changing. Theres still a little bit of raising an eyebrow right now, but its becoming much more acceptable. Some people like to spend money on expensive cars. I like to spend money on myselfI consider my body to be the vehicle I drive in.

For some, cosmetic procedures fit smoothly into the narrative of personal empowerment and the growing idea that you can create yourself: your gender, your face, your identity. Its the old American idea of self-improvement, sliced and diced for the 21st century. Behavior that would once have seemed narcissistic has been reframed as an act of self-care. For starters, technology means theres no longer any need to tolerate physical imperfection. Plus, while millennials are accepting of quirky traits and would be loath to admit to holding a single ideal aesthetic, they also consider the very notion of judging other peoples lifestyle choices so old-fashioned that any taboo surrounding cosmetic enhancements seems like a relic from another era. So lets all get lip fillers.

And they will: Millennials are nearly twice as likely as people over 35 to be considering a cosmetic procedure in the next year, according to a poll last year by RealSelf, a cosmetic-surgery review website. The trend is toward transparency and removal of stigma for everything to do with self-care and self-love, says Simon Ourian, M.D., whom Kylie Jenner has credited forher signature pout with Juvederm, an investment on which Jenner has since built a nine-figure cosmetics business.

More cosmetic work is done in the United States than in any other country, according to a study by the International Society of Aesthetic Plastic Surgery. In 2018, the last year for which figures are available, the American Society of Plastic Surgeons (ASPS) reports that Americans spent a record $16.5 billion on plastic surgery and its twin progeny, Botox and fillers. Botox and other botulinum-toxin brands accounted for 42 percent of the 17.7 million procedures performed in the US by plastic surgeons that year. The real number of such injections is far higher, because they are also routinely dispensed by dentists, dermatologists, ophthalmologists and even walk-in beauty bars.

Adobe

More men are being seduced by these speedy pick-me-ups as the barriers to entry, both practical and social, diminish. In the US, male use of fillers and Botox has risen by 101 percent and 381 percent, respectively, since 2000, according to the ASPS, while the number of surgical nose jobs has dropped by 65 percent. Demand for handsome noses has not declined: Its just that many men now have their noses adjusted with less daunting fillers instead, according to Alan Matarasso, M.D., a plastic surgeon on New Yorks Upper East Side.

All the leading cosmetic surgeons and dermatologists interviewed for this article say men account for 20 to 35 percent of their clientele, a proportion that is growing while also broadening in scope. As with most style trends, gay men were the first to catch on. Then came the metrosexual type that would come in for Botox after their manicure, as David Mabrie, M.D., a facial plastic surgeon in San Francisco, recounts. Now its more mainstream guys. Guys guys. Men who a few years ago would have considered it a burden to trim a four-inch hair growing out of their ear are now smoothing their fine lines and filling their nasolabial folds.

In New York, the male clientele for Gerald Imber, M.D., has changed from largely those in entertainment to 95 percent CEOs and similarly accomplished professionals. These guys spend more on jet fuel coming to New York than they do on me, he says. Fifteen years ago, says Ourian, his Los Angeles patients were likely to be in entertainment, but the trend has completely changed and they are now from all walks of life. He adds that his practice includes ultra-wealthy businessmen, politicians, heads of state, three kings and five queens.

Even so, enough residual stigma remains that most men keep their Botox habits secret. And for some, the thrill of a clandestine hobby is part of the appeal. Marc likens it to membership in an exclusive club. One of Imbers patients, a 67-year-old real-estate developer from New Jersey, whom well call Nick, also relishes being a member of a secret elite club, in which the members are unknown even to each other. No one knows about it, he says. Thats just my masculine insecurityits a vanity issue. I work a lot with the construction industry, and no one there goes into work and says, I just had a face-lift.

Adobe

Nick felt that his jowly, hangdog face didnt match his gym-honed physique. I thought, If I cut my head off, I would look a lot younger, he says with a chuckle. But before I do that, Ill see if Dr. Imber can help. So three years ago, he took his girlfriend, whos 20 years his junior, for some couples liposuctionthat was the test runand followed up with a facelift.

I checked into the Carlyle, stayed three days, took the wrappings off and went home, Nick recalls. When I went out, I ran into people I knew at a restaurant. They asked if Id been on vacation. He describes with delight how he was asked for ID at a senior citizens lockdown shopping hour at a grocery store in the Hamptons.

Age has become elastic. On the one hand, Nick does not consider himself old at 67, but in youth-obsessed Silicon Valley, 35 is thought over the hill. There, the surgery is starting younger and younger, as tech-industry executives, who are mostly male, strive to appear relevant to their millennial overlords.

Larry Fan, M.D., a San Francisco plastic surgeon, says his clients now describe a work culture where if theyre over 30 they feel less relevant. Their work involves providing services to younger consumers, and tech luminaries are very young. My patients who are in their 50s say, Im the old guy in the room, and I dont want to feel that way. Young people have a kind of OK boomer mentality.

Fan says his male patients ask to look like Elon Musk: Hes aspirational for his work and [looks like he] has had some enhancements done, hair transplants and other things. He looks like a normal person but masculine and chiseled.

Elon MuskAP

Some of Fans patients, whom he describes as senior tech billionaires with famous names, regard cosmetic procedures as a form of bio-hacking (see here). Their mentality is: I want to live forever if I can find a way, Fan says. I believe in technology, and part of that is new treatments that help me have fewer wrinkles.

Ageism in the tech industry is not confined to Silicon Valley, according to one recruitment executive who worked with software start-ups in New York. The hiring managers were in their 30s, he explains. There are laws against saying youre looking for someone young, so instead they would say we need a culture fit. That was the number-one most important factor. Theyre looking for someone to grab a beer with. The recruiter put it down to the hubris that comes with gaining a lot of power at an early age. It means that they dont think they can learn anything from an older person. They feel invincible.

George, 53, the CEO of a large software company in the Bay Area, agrees that a youthful demeanor is a prerequisite in tech. Whatever HR says, you do look at pictures when you hire someone, and you look at their digital footprint, he says. Are they the right cultural fit? Do they take care of themselves? For better or worse, when you hire someone for a high-stress, high-performance job, part of that is their appearance.

In 2010, five years after Georges divorce from his first wife, his daughters took charge of his online dating profile. Being millennials, they said you have to look great online, he recalls. I realized that pictures had become very important, not just from a dating perspective but also on LinkedIn. That was a turning point for me.

He had dabbled in Botox but, with that revelation, became a devotee. A dermatologist who I played golf with said, If you want to stay looking like that, come in. I kept it up until I was 50, then I added fillers once a year, to keep the volume of my face, George says. Last year, he went to Sachin Parikh, M.D., a Palo Alto surgeon, for a hair transplant. George keeps the procedures private, partly as a career strategy. I dont want to talk about it because its still perceived as less manly. Also, men dont like to share tricks that may make them more competitive in the market. I do cryotherapy, I ride the Peloton every day and Ive had all the genetic testing to see what [conditions] I am predisposed to have, what foods do I process well. I see it all on the same spectrum as bio-hacking.

Adobe

The paradox of a man being furtive about a procedure he claims is akin to watching his sugar intake is surprisingly common. Talking about going to the gym is OK. Talking about getting a haircut is OK, says Imber. But cosmetic procedures are something they will do for themselves only, and they do not talk about it. In a culture of secrecy, it can be hard for surgeons to attract male clients through word of mouth. But once men are through the door, they keep coming back. Parikh describes the typical profile: The majority have dabbled in teeth whitening and skin care, and they work their way up the ladder from collagen stimulating treatments to fillers and Botox.

Hair-loss consultations can also be a gateway drug to other treatments, says Jessie Cheung, M.D., a Chicago-area dermatologist. A man will typically come in to talk about losing his hair, and we check for hormone deficiencies, she says. If their testosterone is not optimized, I will explain the benefits, and of course they want to perform better. Most clients who come for hormone therapy often get cosmetic treatments, too, and vice versa.

Other in-demand body treatments for men include CoolSculpting, a form of nonsurgical fat removal using cryotherapywildly popular, according to Fan, whose clientele for the procedure is 50 percent maleand skin tightening using ultrasound (Ultherapy) or radio frequency (FaceTite). But injectables are the money-spinner: a 12-year bull run of year-on-year double-digit growth, says Parikh.

Adobe

Paul Nassif, M.D., a facial surgeon famous for his TV appearances fixing bad surgery on the E! News show Botched, believes men are becoming more susceptible to the pressures of Instagram perfection. They are now on the same track as women, he says. Eight years ago, men were using Botox for work. Now I would say they are trying to make themselves look better on social media.

With fillers they can look like a filtered photo. We call it selfie dysmorphia. One of the biggest cosmetic trends of last year was the growth of reversal treatments for faulty fillers and surgical procedures, with liposuction revision up by 183 percent, according to RealSelf.

In New York, Matarasso is expecting a flood of business as soon as lockdown restrictions ease, after months of financiers, lawyers and such inspecting their double chins on Zoom. He believes that the crazy unemployment rate will lead to more treatments as job applicants grow desperate to gain an edge over their peers.

As demand for cosmetic enhancement rises, any remaining stigma, even among the middle-aged, seems likely to die away. When I talk about it with my close friends, I find a lot of them do it, too, says George, the software CEO. Its dont ask, dont tell, but when you do ask, they do tell.

More here:
Why Men Are Turning to Cosmetic Procedures for a Competitive Edge in the Boardroom - Robb Report

Posted in Testosterone | Comments Off on Why Men Are Turning to Cosmetic Procedures for a Competitive Edge in the Boardroom – Robb Report

Global Testosterone Replacement Therapy Market By Covid-19 Impact Analysis, Size, Regional Growth, Major Key Players, Technology And Industry Trends…

Posted: August 16, 2020 at 7:48 am

The research report entitled on the Global Testosterone Replacement Therapy Market offers useful understandings into the trends and factors that drive this market. This report provides wide-ranging analysis on market status and development trend, including types, applications, rising technology, and the region also it covers the current and past market scenarios, market development outlines, and is expected to proceed with a continuing development over the forecast period. A number of analysis tools such as SWOT analysis and Porters five forces analysis have been employed to provide a correct understanding of this market.

The Testosterone Replacement Therapy Market revenue was US$ XX.XX Million in 2020, and will reach XX.XX Million USD in 2024, with CAGR of x.x%, is expected to be registered during the forecast period 2020-2024.

Request Sample Copy of Testosterone Replacement Therapy Market @: https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#request_sample

Some of the Key Players of the Testosterone Replacement Therapy Market:

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

This newest report, covering the current COVID-19 impact on the market. The disease of Coronavirus (COVID-19) has impacted every aspect of life totally. This has taken along with numerous changes in market conditions.

Some of the geographic regions examined in the overall Testosterone Replacement Therapy Market are:

Get Huge Discount on this Report:https://www.globalmarketers.biz/discount_inquiry/discount/129647

Testosterone Replacement Therapy Market By Type:

GelsInjectionsPatchesOther

Based on end-user/application, this report focuses on the status and outlook for major applications:

HospitalsClinicsOthers

The Testosterone Replacement Therapy Market research provides answers to the following key questions:

Inquire Before [emailprotected]https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#inquiry_before_buying

Key Points of this Testosterone Replacement Therapy Market report:

Fundamentals of Table of Content:

Get Full Table of Content @ https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#table_of_contents

See the article here:
Global Testosterone Replacement Therapy Market By Covid-19 Impact Analysis, Size, Regional Growth, Major Key Players, Technology And Industry Trends...

Posted in Testosterone | Comments Off on Global Testosterone Replacement Therapy Market By Covid-19 Impact Analysis, Size, Regional Growth, Major Key Players, Technology And Industry Trends…

Impact of COVID-19 on Global Testosterone Replacement Therapy Market Is Expected To Witness Significant Gains During 2020-2027 | Endo Pharmaceuticals,…

Posted: August 14, 2020 at 11:48 pm

The report offers a systematic presentation of the existing trends, growth opportunities, market dynamics that are expected to shape the growth of the Testosterone Replacement Therapy Market. The various research methods and tools were involved in the market analysis, to uncover crucial information about the market such as current & future trends, opportunities, business strategies and more, which in turn will aid the business decision-makers to make the right decision in future.

Whats keeping AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc. Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by CMI

Request a sample copy:https://www.coherentmarketinsights.com/insight/request-sample/2024

List of Companies Mentioned:AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

1) Does Study provides Latest Impact on Market due to COVID & Slowdown?

Yes study have considered a chapter on Impact Analysis and this 2020 Edition of the report provides detailed analysis and its impact on growth trends and market sizing to better understand current scenario.

2) How companies are selected or profiled in the report?

List of some players that are profiled in the the report includes AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.. list is sorted to come up with a sample size of atleast 50 to 100 companies having greater topline value to get their segment revenue for market estimation.

** List of companies mentioned may vary in the final report subject to Name Change / Merger etc.

3) Is it possible to narrow down business segments by Application of this study?

Yes, depending upon the data availability and feasibility check by our Research Analyst, further breakdown in business segments by end use application in relation to type can be provided (If applicable) by Revenue Size or Volume*.

4) What is the base year of the study? What time frame is covered in the report?

Furthermore, the years considered for the study are as follows:

Historical year 2016 2019

Base year 2019

Forecast period** 2020 to 2027 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

Detailed Segmentation:

By Active Ingredient TypeTestosteroneMethyl TestosteroneTestosterone UndecanoateTestosterone EnanthateTestosterone CypionateBy Route of AdministrationInjectablesParenteral

Regions included:

o North America (United States, Canada, and Mexico)

o Europe (Germany, France, UK, Russia, and Italy)

o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

o South America (Brazil, Argentina, Colombia)

o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Global Testosterone Replacement Therapy Market What to expect from this report:

Focused Study on Niche Strategy and Market Development & penetration Scenario

Analysis of M&As, Partnership & JVs in Global Testosterone Replacement Therapy Industry in United States & Other Emerging Geographies

Top 10 Global Testosterone Replacement Therapy Companies in Global Market Share Analysis: Leaders and Laggards in 2017, 2020

Gain strategic insights on competitor information to formulate effective R&D moves

Identify emerging players and create effective counter-strategies to outpace competitive edge

Identify important and diverse product types/services offering carried by major players for market development

And many more .

TABLE OF CONTENTS

Report Overview:It includes the Testosterone Replacement Therapy market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary:This section of the report gives information about Testosterone Replacement Therapy market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players:Here, key players of the Testosterone Replacement Therapy market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study:All of the regions and countries analyzed in the Testosterone Replacement Therapy market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Download PDF Brochure @https://www.coherentmarketinsights.com/insight/request-pdf/2024

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide.

Mr Raj ShahCoherent Market Insights 1001 4th Ave,#3200 Seattle, WA 98154, U.S.Phone +1-206-701-6702[emailprotected]

Read more here:
Impact of COVID-19 on Global Testosterone Replacement Therapy Market Is Expected To Witness Significant Gains During 2020-2027 | Endo Pharmaceuticals,...

Posted in Testosterone | Comments Off on Impact of COVID-19 on Global Testosterone Replacement Therapy Market Is Expected To Witness Significant Gains During 2020-2027 | Endo Pharmaceuticals,…

Helping Transgender Patients Reap the Benefits & Navigate the Challenges of Hormone Therapy – NYU Langone Health

Posted: August 13, 2020 at 4:52 pm

For people with gender dysphoria, hormone therapy can significantly reduce mental distress and improve quality of life. NYU Langones multidisciplinary transgender program takes an intensely personalized approach to these treatments, centered on the individual patients goals, life circumstances, comorbidities, and evolving clinical response.

Although many medical centers offer gender-affirming hormone therapy, NYU Langone does so under the direction of an endocrinologist who specializes in transgender care. For these patients, the clinicians expertise can be crucial to optimizing outcomes, explains Michele B. Glodowski, MD, clinical instructor in the Department of Medicine, whose fellowship training included extensive clinical rotations at the University of Colorados Integrated Transgender Program.

Gender-affirming hormone therapy typically uses different doses and modalities from hormone replacement therapy for postmenopausal cisgender women or cisgender men with low testosterone. The risk of complications, including certain types of cancer, may be heightened as well. With testosterone, we often see weight gain, changes in LDL and HDL cholesterol, elevations in hematocrit, and increases in insulin resistance and blood pressure, Dr. Glodowski notes. Feminizing regimens, such as estradiol, can also trigger weight gain, raise the risk of cardiovascular disease, and often affect liver enzymes and triglycerides.

Besides enhancing her ability to monitor and manage side effects, Dr. Glodowskis training helps her tailor treatment to patients unique needs. Theres a whole spectrum of gender identity and gender expression, she says, so its important to provide a whole spectrum of care. It looks different for every individual. Some patients, for example, may identify as definitively male or female, others as nonbinary or gender-fluid. Some may choose to have hormone therapy in conjunction with gender confirmation surgery; others may choose hormonesor surgeryalone. And a wide range of external factors may influence patients therapeutic pathways.

Theres a whole spectrum of gender identity and gender expression, so its important to provide a whole spectrum of care.Michele B. Glodowski, MD

Even in 2020, people still lose their jobs or get kicked out of their homes because theyre trans, Dr. Glodowski observes. I want to make sure patients are comfortable with all the social aspects that can come into play with gender transition. If someone says, Im not ready to come out at work yet, we might slow the process down a bit. If they say, my parents have 30,000 questions, we might arrange a visit with mom and dad. Patients may wish to have their eggs or sperm frozen before hormone therapy begins, to preserve their fertility. Those who do sex work might benefit from screening for sexually transmitted diseases, or consultation with a social worker who can connect them with supportive services.

In collaboration with her colleagues in the multidisciplinary transgender programwhose specialties include plastic surgery, gynecology, and urology, in addition to endocrinologyDr. Glodowski is able to ensure that patients receive precisely the care they require.

NYU Langone Health has been certified for 7 consecutive yearswith a score of 100 percentby the Human Rights Campaign Foundation Healthcare Equality Index Report, which evaluates the work of medical facilities in providing equal healthcare access to LGBTQ+ Americans. One factor in that success is the centers patient-centered approach to transgender care.

In some practices, patients can walk into the office and have someone use the wrong pronoun, Dr. Glodowski says. The doctor might see them briefly, write a prescription, and thats basically it. At NYU Langone, everyone from the receptionists to the medical assistants to the physicians have been trained to be sensitive to gender identity. I spend 40 minutes with each new patient, and 20 minutes with any follow-ups. In addition, we have one clinic a week specifically dedicated to gender-affirming hormone therapy.

The 2019 coronavirus disease (COVID-19) pandemic has also made telehealth a crucial component of the transgender programs endocrinology practice. Although the crisis has waned in New York City, many patients prefer to continue with video visitsciting both safety and convenienceafter an initial in-person consultation. At the height of the pandemic, many providers turned to telehealth to limit in-person visits for non-urgent care, Dr. Glodowski explains. But there is a high rate of suicidal ideation and suicide in patients who are trans-identified. For this patient group, almost all care can be described as urgent, especially for someone whos new to hormones and may be experiencing severe dysphoria.

With those who are beginning a course of hormone therapy, Dr. Glodowski typically schedules a video visit to discuss treatment goals, the expected timeline of physiological changes, and potential side effects. We want to make sure that every patient is very well informed, she explains. As treatment progresses, she will order lab work and discuss results with patients via video link, as well as checking on therapeutic progress and the patients comfort level with the regimen.

Whether a visit is in-person or remote, she adds, its always essential that we provide patients with a safe, gender-affirming space.

See the article here:
Helping Transgender Patients Reap the Benefits & Navigate the Challenges of Hormone Therapy - NYU Langone Health

Posted in Testosterone | Comments Off on Helping Transgender Patients Reap the Benefits & Navigate the Challenges of Hormone Therapy – NYU Langone Health

Platelet rich plasma and thicker hair | Health Wellness – NorthFulton.com

Posted: August 13, 2020 at 4:52 pm

Everyone would like to have thicker hair. Well, almost everyone -- but our focus today is not on those rare unicorns whose complaint is that their hair is just too thick, too luxurious and too lustrous. This article is for the rest of us who would like to have more or thicker hair or at least stop losing what we have.

A number of treatment options have been the staple considerations for normal male and female pattern hair loss for years. For men, finasteride, minoxidil and hair transplantation have long been the most effective interventions. Womens treatment options used to be even more limited, with minoxidil alone being the main option for female pattern hair loss. However, a growing body of research supports that hormone replacement and/or platelet rich plasma injections could be the miracle grow for failing follicles!

First, a note about hormone replacement therapy: A physician named Dr. Glaser published an article in the British Journal of Dermatology in 2012 which made an observation that has unfortunately gained little attention likely because it runs counter to how people usually think about hair loss and testosterone. Dr. Glaser surveyed 285 women who had been on subcutaneous testosterone therapy for more than a year for the treatment of androgen deficiency and 63% of the women who had reported hair thinning prior to treatment reported hair thickening after treatment began. This finding has received little attention, but a 63% response rate deserves further investigation.

Several patients in my own clinic who complained of thinning hair, went on androgen replacement prescribed by their endocrinologist or ob-gyn for other reasons. These patients hair became markedly thicker and more voluminous on testosterone. Although Premier Dermatology does not offer hormone replacement therapy (HRT), androgen levels are one of the laboratory tests that we order as part of our screening panel for causes of hair loss. If we have a female hair loss patient with low androgen levels (either low or low normal), we offer referral to a physician who performs HRT for discussion of risks and benefits of a trial of androgen replacement therapy for hair loss. Results that we have seen have paralleled the 63% response rate that Dr. Glaser published.

Second and just as exciting, Platelet Rich Plasma, also known as PRP, is an option that is fast becoming an important treatment strategy for treating hair loss in both men and women, be it for common hair thinning or for certain alopecia syndromes. PRP is a blood product derived from a patients own blood. The process involves the following: A fraction of blood (up to 22ml in our practice) is drawn from the individual patient into a syringe (depends on the extent of hair loss). This is a relatively small amount compared to blood donation. The blood then is spun in a centrifuge to separate its components (White & Red Blood Cells, Platelet Rich Plasma and Platelet Poor Plasma). The Platelet Rich Plasma (PRP) is collected into a syringe. The PRP is then injected into a treatment area (the scalp for hair loss).

The basis behind PRP is that growth factors and other proteins within platelets promote healing and induce tissue regeneration and rejuvenation. Platelets contain growth factors and biologically active molecules that are normally released when platelets are outside of blood vessels such as when a person gets a cut and starts to bleed into surrounding tissue. Injecting PRP into the subdermal fat induces platelet degranulation (release of platelet contents) which causes tissue exposure to platelet growth factors. In plain terms, PRP delivers growth factors to stimulate hair follicles.

To achieve best results, PRP is performed in a series of treatments. Typically, two to three treatments are performed once per month initially. It is often recommended that treatments take place every 6 months after the initial series of treatments to continue hair regeneration and maintain or enhance results.

PRP has numerous other applications in dermatology the most common of which is as an adjunct to microneedling for skin rejuvenation or treatment of acne scars. However, PRPs greatest potential may be as a treatment to help grow or maintain hair.

At Premier Dermatology and Mohs Surgery of Atlanta, we are committed to offering scientifically-backed, effective and state of the art treatments. Kathryn Filipek, PA-C has extensive cosmetic, surgical and medical dermatology experience and is responsible for the hair loss branch of our practice. If you are interested in exploring PRP and hair loss options, call today to make an appointment with Ms. Filipek. It is our privilege to take care of you and your familys skin, vein, and hair care needs.https://premierdermatologyatlanta.com/

See more here:
Platelet rich plasma and thicker hair | Health Wellness - NorthFulton.com

Posted in Testosterone | Comments Off on Platelet rich plasma and thicker hair | Health Wellness – NorthFulton.com

Testosterone Replacement Therapy Market 2020 Global COVID-19 Impact, Strategies, Overview and Forecast to 2027 – The Daily Chronicle

Posted: August 13, 2020 at 4:52 pm

The Latest research report on the Global Testosterone Replacement Therapy Market 2020 sheds light on the crucial aspects influencing the advancement of the market. Not only are the market opportunities revealed, but the inhibiting factors preventing the development of the market have also been discussed, following a comprehensive summary. With a view to better inform the buyers, the report takes into consideration the various limitations and strengths of the leading companies operating in the market. Their product portfolios as well as the recent business strategies adopted by them have also been talked about. The competitive developments such as research and development activities, partnerships, product innovations, and mergers and acquisitions have been analyzed.

Testosterone Replacement Therapy Market report presents the detail analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the industry competitors. Top players in the industry include AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Key players in the Testosterone Replacement Therapy market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All measurement shares, splits, and breakdowns have been resolute using secondary sources and verified primary sources.

Impact of Covid-19 in Testosterone Replacement Therapy Market: The utility-owned segment is mainly being driven by increasing financial incentives and regulatory supports from the governments globally. The current utility-owned Testosterone Replacement Therapy are affected primarily by the COVID-19 pandemic. Most of the projects in China, the US, Germany, and South Korea are delayed, and the companies are facing short-term operational issues due to supply chain constraints and lack of site access due to the COVID-19 outbreak. Asia-Pacific is anticipated to get highly affected by the spread of the COVID-19 due to the effect of the pandemic in China, Japan, and India. China is the epic center of this lethal disease. China is a major country in terms of the chemical industry.

Detailed Segmentation:

By Active Ingredient TypeTestosteroneMethyl TestosteroneTestosterone UndecanoateTestosterone EnanthateTestosterone CypionateBy Route of AdministrationInjectablesParenteral

Testosterone Replacement Therapy Market Regional Analysis Includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Europe (Turkey, Germany, Russia UK, Italy, France, etc.)

North America (the United States, Mexico, and Canada.)

South America (Brazil etc.)

Middle East and Africa (GCC Countries and Egypt.)

Download PDF brochure of this report @https://www.coherentmarketinsights.com/insight/request-pdf/2024

Remarkable Attributes of Testosterone Replacement Therapy Market Report:

The current status of the global Testosterone Replacement Therapy market, current market & the two regional and region level.

In-Depth Understanding of Facets Activating the Development of the global Testosterone Replacement Therapy marketplace.

Current market isolation Relating to Identifying portions like Testosterone Replacement Therapy Merchandise Sort, end-use Software

The innovative perspective of this global Testosterone Replacement Therapy current market with layouts that are standard, and also prime chances.

The research of this market enticing place regarding product sales of Testosterone Replacement Therapy.

Various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Testosterone Replacement Therapy market, research and consulting firms, new entrants, and financial analysts

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide.

Contact US

Coherent Market Insights E-mail:[emailprotected]Tel:+1-206-701-6702Add:1001 4th Ave,#3200 Seattle, WA 98154, U.S.Website:https://www.coherentmarketinsights.com

See the original post here:
Testosterone Replacement Therapy Market 2020 Global COVID-19 Impact, Strategies, Overview and Forecast to 2027 - The Daily Chronicle

Posted in Testosterone | Comments Off on Testosterone Replacement Therapy Market 2020 Global COVID-19 Impact, Strategies, Overview and Forecast to 2027 – The Daily Chronicle

Androgen Replacement Therapy Market potential growth, share, demand and analysis of key players research forecasts to 2028 | AbbVie, Inc., Allergan…

Posted: August 10, 2020 at 7:48 pm

This detailed market study covers androgen replacement therapy market growth potentials which can assist the stake holders to understand key trends and prospects in androgen replacement therapy market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the markets growth potential, which can help investors identify scope and opportunities. The analysis also provides details of each segment in the global androgen replacement therapy market

Get Sample Copy of This Report @https://www.quincemarketinsights.com/request-sample-67631?utm_source=EE&utm_medium=SG

According to the report, the androgen replacement therapy market report points out national and global business prospects and competitive conditions for androgen replacement therapy. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for androgen replacement therapy. The androgen replacement therapy market has been segmented by product type (creams/gels, patches, injections, implants, and oral tablets/capsules/gums), by active ingredient type (testosterone, methyl testosterone, testosterone undecanoate, testosterone enanthate, and testosterone cypionate), by distribution channel (hospitals pharmacies, retail pharmacies, and online pharmacies). Historical background for the demand of androgen replacement therapy has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand androgen replacement therapy have also been established with potential gravity.

Regional segmentation and analysis to understand growth patterns:

The market has been segmented in major regions to understand the global development and demand patterns of this market.

North America, Europe, and Asia Pacific by region are estimated to dominate the androgen replacement therapy market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favourable for the growth of the healthcare infrastructure in these regions. North America and Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for androgen replacement therapy market during the forecast period.

Get ToC for the overview of the premium report @https://www.quincemarketinsights.com/request-toc-67631?utm_source=EE&utm_medium=SG

The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for androgen replacement therapy market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for androgen replacement therapy market in the region. Other regions including Middle East, Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for androgen replacement therapy market during the forecast period.

This report provides:

1) An overview of the global market for androgen replacement therapy market and related technologies.2) Analysis of global market trends, yearly estimates and annual growth rate projections for compounds (CAGRs).

3) Identification of new market opportunities and targeted consumer marketing strategies for global androgen replacement therapy market .4) Analysis of R&D and demand for new technologies and new applications5) Extensive company profiles of key players in industry.

Make an Inquiry for purchasing this Report @https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-67631?utm_source=EE&utm_medium=SG

The researchers have studied the market in depth and have developed important segments such as product type, application and region. Each and every segment and its sub-segments are analyzed based on their market share, growth prospects and CAGR. Each market segment offers in-depth, both qualitative and quantitative information on market outlook.

With an emphasis on strategies there have been several primary developments done by major companies such as AbbVie, Inc., Allergan Plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International Plc, Mylan N.V., Novartis International AG, Pfizer, Inc., Clarus Therapeutics, Ferring Holding SA, Perrigo Company Plc, Acerus Pharmaceuticals Corporation.

Market Segmentation:

By Product Type:o Creams/Gelso Patcheso Injectionso Implantso Oral Tablets/Capsules/Gums.

By Active Ingredient Type:o Hospitals Pharmacieso Retail Pharmacieso Online Pharmacies

By Distribution Channel:o Testosteroneo Methyl Testosteroneo Testosterone Undecanoateo Testosterone Enanthateo Testosterone Cypionate

By Region:

North America Androgen Replacement Therapy Marketo North America, by CountryUSCanadaMexicoo North America, by Product Typeo North America, by Modalityo North America, by Distribution Channel

Europe Androgen Replacement Therapy Marketo Europe, by CountryGermanyRussiaUKFranceItalySpainThe NetherlandsRest of Europeo Europe, by Product Typeo Europe, by Modalityo Europe, by Distribution Channel

Asia Pacific Androgen Replacement Therapy Marketo Asia Pacific, by CountryChinaIndiaJapanSouth KoreaAustraliaIndonesiaRest of Asia Pacifico Asia Pacific, by Product Typeo Asia Pacific, by Modalityo Asia Pacific, by Distribution Channel

Middle East & Africa Androgen Replacement Therapy Marketo Middle East & Africa, by CountryUAESaudi ArabiaQatarSouth AfricaRest of Middle East & Africao Middle East & Africa, by Product Typeo Middle East & Africa, by Modalityo Middle East & Africa, by Distribution Channel

South America Androgen Replacement Therapy Marketo South America, by CountryBrazilArgentinaColombiaRest of South Americao South America, by Product Typeo South America, by Modalityo South America, by Distribution Channel

Reasons to Buy This Report:

o Provides niche insights for decision about every possible segment helping in strategic decision making process.o Market size estimation of the androgen replacement therapy market on a regional and global basis.o A unique research design for market size estimation and forecast.o Identification of major companies operating in the market with related developmentso Exhaustive scope to cover all the possible segments helping every stakeholder in the androgen replacement therapy

Customization:

This study is customized to meet your specific requirements:

o By Segmento By Sub-segmento By Region/Countryo Product Specific Competitive Analysis

Contact:Quince Market InsightsAjay D. (Knowledge Partner)Office No- A109Pune, Maharashtra 411028Phone: US +1 208 405 2835 UK +44 144 439 0986 APAC +91 706 672 4848Email: [emailprotected]Web:www.quincemarketinsights.com

ABOUT US:QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Continued here:
Androgen Replacement Therapy Market potential growth, share, demand and analysis of key players research forecasts to 2028 | AbbVie, Inc., Allergan...

Posted in Testosterone | Comments Off on Androgen Replacement Therapy Market potential growth, share, demand and analysis of key players research forecasts to 2028 | AbbVie, Inc., Allergan…

UB study finds testosterone therapy can lead to remission in men with Type 2 diabetes – UB Now: News and views for UB faculty and staff – University…

Posted: August 10, 2020 at 7:48 pm

The findings from a recent study by a UB researcher and others could prove to be a game-changer for men with Type 2 diabetes.

The single-site study, conducted over 11 years in Bremerhaven, Germany, found that testosterone therapy reversed Type 2 diabetes in one-third of the study participants.

The occurrence of this syndrome is common, and with appropriate testosterone replacement, obesity insulin resistance and diabetes may be reversible, says Paresh Dandona, SUNY Distinguished Professor in the Department of Medicine in the Jacobs School of Medicine and Biomedical Sciences at UB. He co-authored the study, titled Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.

The prospective, registry-based study was published in June in the online journal Diabetes, Obesity and Metabolism. Dandona also presented the data at the Annual Mohan Diabetes Foundation Symposium in Chennai, India, on July 25, where he was given the organizations Lifetime Achievement Award.

Type 2 diabetes, also known as Type 2 diabetes mellitus, results from a combination of insulin resistance and insufficient production of insulin, causing high blood sugar. The condition is common, with more than 3 million new cases per year in the United States. Reduced testosterone concentrations are found in 33% of men with Type 2 diabetes.

The discovery of this syndrome of hypogonadism in Type 2 diabetes was made by Dandonas group at UB in 2004. This group then extended the prevalence of this syndrome to include 25% of non-diabetic obese men in 2010. Thus, diabetes and obesity became the main cause of male hypogonadism. The group went on to demonstrate that such patients have additional insulin resistance that reverses with testosterone treatment in 2016.

Testosterone deficiency, which is also called male hypogonadism, contributes to reduced response of insulin to glucose, increased insulin resistance and eventually the onset of Type 2 diabetes.

The objective of the researchers study was to determine if men with Type 2 diabetes who also exhibit hypogonadism, when treated with testosterone in addition to their regular diabetes treatment, would demonstrate improved glycemic control and insulin sensitivity, and possibly eventually experience remission of Type 2 diabetes.

The investigators observed 356 men in a single urology practice clinic over 11 years. All patients received standard diabetes treatment, which included mandatory educational courses and materials. In addition, 178 men with a mean age of 62 years received 1,000 milligrams of subcutaneously injected, slow-release testosterone every 12 weeks after an initial six-week interval. The 178 subjects, mean age 64 years, who opted out of the testosterone therapy served as the control group.

The researchers took numerous measurements, including height, weight, waist circumference, blood pressure, hemoglobin, fasting glucose, HbA1c (the average amount of glucose in blood over a six- or 12-week period), insulin, heart rate, lipids, highly sensitive C-reactive protein and total testosterone, among others. They also assessed quality of life using the Aging Males Symptoms scale. Erectile function was also assessed, using the International Index of Erectile Function. Assessment of these clinical metrics was performed at least twice a year, and data over 11 years were analyzed.

The results showed that the men treated with testosterone had significant progressive and sustained reductions in their body weight, fasting glucose, HbA1c and fasting insulin over the treatment period, the authors wrote. In the control group, fasting glucose, HbA1c and fasting insulin increased.

One-third (34.3%) of men treated with testosterone saw remission of their diabetes; almost half (46.6%) achieved normal glucose regulation with antidiabetic treatment and a vast majority (83.1%) reached their target level of HbA1c.

Patients in the control group saw no remission of diabetes or reduction in glucose or HbA1c levels.

In addition, there were fewer deaths, myocardial infarctions, strokes and diabetic complications in the group treated with testosterone.

The research indicates that long-term treatment with testosterone is potentially a novel additional therapy for men with Type 2 diabetes and hypogonadism, the authors wrote.

The clinical significance of these results is further enhanced by the fact that one-third of men with Type 2 diabetes have hypogonadism. Hence, physicians encounter men with hypogonadism and diabetes very frequently. It is remarkable that while Type 2 diabetes mellitus leads to hypogonadism, treatment of hypogonadism results in remission of diabetes itself, the authors wrote.

Going forward, prospective randomized controlled trials are needed to confirm the data. One such trial is currently in progress.

Dandona is one of the worlds leading experts in the treatment of diabetes and vascular disease. He is also the ex-chief of endocrinology at UB and founder of the Diabetes and Endocrinology Center of Western New York, which is sponsored by the Jacobs School and Kaleida Heath. He sees patients at UBMD Internal Medicine.

Dandonas co-authors on the study include Karim Sultan Haider and Ahmad Haider, urologists in Bremerhaven, Germany; Farid Saad, a consultant to Medical Affairs Andrology at Bayer AG in Berlin; Gheorghe Doros from the Department of Epidemiology and Biostatistics at the Boston University School of Public Health; Markolf Hanefeld from GWT-TU Dresden GmbH and Medizinische Klinik, Universittsklinikum Carl Gustav Carus, in Dresden; Sandeep Dhindsa from the Division of Endocrinology, Diabetes and Metabolism at Saint Louis University; and Abdulmaged Traish from the Department of Urology at the Boston University School of Medicine.

Read the original:
UB study finds testosterone therapy can lead to remission in men with Type 2 diabetes - UB Now: News and views for UB faculty and staff - University...

Posted in Testosterone | Comments Off on UB study finds testosterone therapy can lead to remission in men with Type 2 diabetes – UB Now: News and views for UB faculty and staff – University…

Testosterone Replacement Therapy Market Demand Forecast Analysis by Emerging Growth Factors and Revenue – Owned

Posted: August 10, 2020 at 7:48 pm

Transparency Market Research (TMR) has published a new report titled, Testosterone Replacement Therapy Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20192027. According to the report, the globalTestosterone Replacement Therapy marketwas valued at US$ 1,613.7 Mn in 2018 and is projected to expand at a CAGR of 4.4% from 2019 to 2027.

Overview

Growing Awareness about Testosterone Replacement Therapy to Drive Market

Request For Covid19 Impact Analysis https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1097

North America to Dominate Global Market

Buy Report Now :https://www.transparencymarketresearch.com/checkout.php?rep_id=1097&ltype=S

Read our Case study at :https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Competitive Landscape

The global Testosterone Replacement Therapy market has been segmented as follows:

More Trending Reports by Transparency Market Research 1.https://www.prnewswire.com/news-releases/global-chronic-obstructive-pulmonary-disease-copd-treatment-market-to-reach-us-26-2-bn-in-2027-drug-makers-focus-on-combination-therapies-transparency-market-research-301011476.html

Continue reading here:
Testosterone Replacement Therapy Market Demand Forecast Analysis by Emerging Growth Factors and Revenue - Owned

Posted in Testosterone | Comments Off on Testosterone Replacement Therapy Market Demand Forecast Analysis by Emerging Growth Factors and Revenue – Owned

Testosterone Replacement Therapy Industry Market 2020: Trends, Size, splits by Region & Segment, Historic Growth Forecast to 2025 – AlgosOnline

Posted: July 9, 2020 at 11:48 am

Worldwide Global Testosterone Replacement Therapy Industry Market report of 2020 provides a detailed market overview as well as industry analysis for / of companies, manufacturers and distributors covering data on gross margin, cost structure, value, sale price and more.

The Testosterone Replacement Therapy Industry market report is an in-depth analysis of this business space. The major trends that defines the Testosterone Replacement Therapy Industry market over the analysis timeframe are stated in the report, along with additional pointers such as industry policies and regional industry layout. Also, the report elaborates on the impact of existing market trends on investors.

Request a sample Report of Testosterone Replacement Therapy Industry Market at:https://www.marketstudyreport.com/request-a-sample/2768774?utm_source=Algosonline.com&utm_medium=AN

COVID-19, the disease it causes, surfaced in late 2020, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

Other information included in the Testosterone Replacement Therapy Industry market report is advantages and disadvantages of products offered by different industry players. The report enlists a summary of the competitive scenario as well as a granular assessment of downstream buyers and raw materials.

Revealing a gist of the competitive landscape of Testosterone Replacement Therapy Industry market:

Ask for Discount on Testosterone Replacement Therapy Industry Market Report at:https://www.marketstudyreport.com/check-for-discount/2768774?utm_source=Algosonline.com&utm_medium=AN

An outlook of the Testosterone Replacement Therapy Industry market regional scope:

Additional takeaways from the Testosterone Replacement Therapy Industry market report:

This report considers the below mentioned key questions:

Q.1. What are some of the most favorable, high-growth prospects for the global Testosterone Replacement Therapy Industry market?

Q.2. Which products segments will grow at a faster rate throughout the forecast period and why?

Q.3. Which geography will grow at a faster rate and why?

Q.4. What are the major factors impacting market prospects? What are the driving factors, restraints, and challenges in this Testosterone Replacement Therapy Industry market?

Q.5. What are the challenges and competitive threats to the market?

Q.6. What are the evolving trends in this Testosterone Replacement Therapy Industry market and reasons behind their emergence?

Q.7. What are some of the changing customer demands in the Testosterone Replacement Therapy Industry Industry market?

For More Details On this Report: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-testosterone-replacement-therapy-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020

Related Reports:

1. COVID-19 Outbreak-Global Fan Data Analytics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020Read More: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-fan-data-analytics-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020

2. COVID-19 Outbreak-Global Big Data In The Oil And Gas Sector Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020Read More: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-big-data-in-the-oil-and-gas-sector-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020

Related Report : https://www.marketwatch.com/press-release/vaginal-specula-market-size-to-accrue-109457-mn-by-2027-2020-07-08?tesla=y

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

See the article here:
Testosterone Replacement Therapy Industry Market 2020: Trends, Size, splits by Region & Segment, Historic Growth Forecast to 2025 - AlgosOnline

Posted in Testosterone | Comments Off on Testosterone Replacement Therapy Industry Market 2020: Trends, Size, splits by Region & Segment, Historic Growth Forecast to 2025 – AlgosOnline

Page 31«..1020..30313233..4050..»